Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CHTL - Things Dreams Are Made Of..... -- Ignore unavailable to you. Want to Upgrade?

To: Howard C. who wrote (703)	6/1/1999 1:18:00 AM
From: KS	Respond to of 746

Regarding Zurich, all I could find was an excerpt on pg 19 of an old class action suit. It reads: "Currently, according to Burnison, the company cannot produce enough Ethocyn to meet the demand. Chantal is negotiating with an independent laboratory in Zurich, Switzerland to synthesize the drug, after a deal to purchase a laboratory in Tucson, Arizona fell through in early September because of the high cost of repairing the facility. securities.stanford.edu I guess she negotiated the deal!!! Hmmmmm..... KS